SCHEMBL19953040

SCHEMBL19953040

COc1ccc(/N=C/c2c(F)cc(F)cc2F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.50
S100B P04271 1/20 0.49
ALDH1A1 P00352 3/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
MAPT P10636 4/20 0.47
MEN1 O00255 3/20 0.47
GAA P10253 3/20 0.47
LMNA P02545 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
PTGS2 P35354 3/20 0.47
PTGS1 P23219 1/20 0.47
CA12 O43570 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
ACHE P22303 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
PTK2B Q14289 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1225547 0.77 ALDH1A1 (0.42) KMT2AALDH1A1L3MBTL1MAPTMEN1
SCHEMBL1225545 0.77 ALDH1A1 (0.42) KMT2AALDH1A1L3MBTL1MAPTMEN1
SCHEMBL1110733 0.77 CYP1A2 (0.45) KMT2AALDH1A1L3MBTL1MAPTMEN1
SCHEMBL11410209 0.77 CYP1A2 (0.42) KMT2AALDH1A1L3MBTL1MAPTMEN1
SCHEMBL11410203 0.77 CYP1A2 (0.42) KMT2AALDH1A1L3MBTL1MAPTMEN1
SCHEMBL5437012 0.76 S100B (0.70) KMT2AS100BALDH1A1L3MBTL1MAPT
SCHEMBL2904627 0.76 S100B (0.70) KMT2AS100BALDH1A1L3MBTL1MAPT
SCHEMBL2904629 0.76 S100B (0.70) KMT2AS100BALDH1A1L3MBTL1MAPT
SCHEMBL5437008 0.76 S100B (0.70) KMT2AS100BALDH1A1L3MBTL1MAPT
SCHEMBL12416630 0.72 S100B (0.82) KMT2AS100BALDH1A1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048969-A1 MULTI-TARGETED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-03-15 WO disclosed